How an Army of Pharma Lobbyists in Washington Have Locked in One of the Biggest Corporate Ripoff Schemes in America @alternet:
"Drug companies have devised elaborate schemes for drug sales to states. The Texas attorney general's office charged Janssen with bribing Texas' mental health officials with trips, perks and kickbacks. Janssen also paid drug company-funded front groups, disguised to look like patients, to "give state mental health officials and lawmakers the perception that the drug had widespread support," reported Bloomberg. Many alleged patient groups agitating for approval of expensive new drugs or fighting so-called "barriers" to treatment and mental illness "stigma" are actually slick drug company marketing creations. Many are entrenched in schools and on college campuses to capture "psychiatric patients" at an early age, often ensuring decades of sales. In Texas, a Medicaid "decision tree" called the Texas Medical Algorithm Project was instituted that mandates doctors prescribe the newest and most expensive psychiatric drugs first. The program was funded, not surprisingly, by the Johnson & Johnson-linked Robert Wood Johnson Foundation. Another tactic drug companies use is "helping" states buy their own brand-name drugs. No conflict of interest there! An Eli Lilly-backed company named Comprehensive Neuroscience "helped" 24 states use Zyprexa "properly," reported the New York Times."
